RecruitingNot Applicable

Quantification & Classification of Inflammatory Cells in Uveitis Using OCT

United States125 participantsStarted 2024-09-01

Plain-language summary

The goal of this study is to determine if it's possible to use a high resolution imaging device called optical coherence tomography (OCT) to develop an unbiased, standard method of counting and categorizing the various types of cells and proteins found in an eye condition called anterior uveitis. Anterior uveitis is a type of inflammation in the eye that can be caused by many different diseases of the body.

Who can participate

Age range5 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Uveitis Group: Eyes with active intraocular inflammation and a clinical diagnose of spondyloarthritis/HLA-B27 associated anterior uveitis, Juvenile Idiopathic Arthritis (JIA) associated chronic anterior uveitis, Herpes Simplex Virus (HSV) anterior uveitis, Birdshot chorioretinitis, Behcet disease uveitis, sarcoidosis associated uveitis, uveitis of any additional type, or uveitis masquerade.
✓. Posterior Vitreous Detachment Group: Eyes with vitreous floaters and posterior vitreous detachment (PVD).
✓. Healthy/Control Group: Healthy eyes with no history of uveitis, PVD, or previous eye surgery.

Exclusion criteria

✕. Inability to give informed consent.
✕. Inability to maintain stable fixation for OCT imaging.
✕. Inability to commit to required visits to complete the study.
✕. Pregnancy and breastfeeding.

What they're measuring

Identification & Measurement of Anterior Chamber Cells

Timeframe: Day 1

Trial details

NCT IDNCT07065747

SponsorOregon Health and Science University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-09

Contact for this trial

Humberto Martinez, COT, MBA

503-494-7712 martinhu@ohsu.edu

View on ClinicalTrials.gov More Anterior Uveitis (AU) trials